Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
Breast Cancer Research and Treatment|December 21, 2004
Effect of dietary glutamine on tumor glutathione levels and apoptosis-related proteins in DMBA-induced breast cancer of ratsValentina K Todorova, Stacy A Harms, Yihong Kaufmann, et al.
Inorganic Chemistry|May 13, 2016
Octafluorodirhenate(III) Revisited: Solid-State Preparation, Characterization, and Multiconfigurational Quantum Chemical CalculationsSamundeeswari Mariappan Balasekaran, Tanya K Todorova, Chien Thang Pham, et al.
Akusherstvo I Ginekologiia|August 26, 2010
[Our and foreign experience in surgical treatment of CIN III-cold knife conisation versus LLETZ]M Boyadzhieva, I Atanassova, V Dimitrova, et al.
The Journal of Chemical Physics|June 30, 2007
Oxygen adsorption on Mo(112) surface studied by ab initio genetic algorithm and experimentMarek Sierka, Tanya K Todorova, Joachim Sauer, et al.
Akusherstvo I Ginekologiia|August 26, 2010
[Screening for gestational diabetes in Bulgaria--preliminary results]M Bojadzhieva, I Atanassova, V Dimitrova, et al.
Plos One|December 5, 2012
Transcriptome profiling of peripheral blood cells identifies potential biomarkers for doxorubicin cardiotoxicity in a rat modelValentina K Todorova, Marjorie L Beggs, Robert R Delongchamp, et al.
Dalton Transactions (Cambridge, England : 2003)|November 3, 2010
First emission studies of Tc2X8(2-) systems (X = Cl, Br)Breeze N Briggs, David R McMillin, Tanya K Todorova, et al.
International Journal of Molecular Sciences|September 14, 2024
Neutrophil Biomarkers Can Predict Cardiotoxicity of Anthracyclines in Breast CancerValentina K Todorova, Gohar Azhar, Annjanette Stone, et al.
American Journal of Cancer Research|October 12, 2020
Biomarkers of inflammation, hypercoagulability and endothelial injury predict early asymptomatic doxorubicin-induced cardiotoxicity in breast cancer patientsValentina K Todorova, Ping-Ching Hsu, Jeanne Y Wei, et al.
Plos One|April 17, 2020
Genome-wide DNA methylation signatures to predict pathologic complete response from combined neoadjuvant chemotherapy with bevacizumab in breast cancerPing-Ching Hsu, Susan A Kadlubar, Eric R Siegel, et al.
Pageof 11